The Allstate Corporation (ALL · NYSE)

Allstate shares have fallen 11.3% over the past month to $227.60, with RSI(14) at 18 and the stock 8.9% below its 20-day moving average, even as it sits 2.3% above its 200-day SMA. Fundamentals remain strong: the company beat estimates in all four of its last quarters, including Q2 2026 EPS of $8.99 versus $5.76 expected, and grew earnings 61.2% year over year on 11.8% revenue growth to $70.14B TTM. The June quarter showed sequential improvement, with revenue of $18.60B and net income of $3.27B, up from $16.94B and $2.46B in March. Valuation screens cheap at a 4.56 P/E and 1.83 P/B, with a 46.1% ROE, $2.59B in quarterly free cash flow, and an analyst target of $276.09; Mizuho maintained a Buy with a $300 target on September 24.